echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Two new crown neutralizing antibody therapies have been approved by the EU to fight the new crown and add new weapons

    Two new crown neutralizing antibody therapies have been approved by the EU to fight the new crown and add new weapons

    • Last Update: 2021-12-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, the European Medicines Agency (EMA) announced that the European Union has approved the listing of two new crown monoclonal antibody drugs


    Ronapreve is approved for the treatment of adults and adolescent patients (over 12 years old and weighing at least 40 kg) who do not require supplemental oxygen and are at increased risk of disease deterioration.


    Ronapreve, jointly developed by Roche and Regeneron Pharmaceuticals, is a combination therapy consisting of two neutralizing antibodies targeting different epitopes of the new coronavirus spike protein


    Regkirona's approval is supported by positive data from Phase 3 clinical trials


    Neutralizing antibodies, as a treatment method for the new coronavirus, can also provide effective treatment for patients with low immunity


    Reference materials:

    [1] COVID-19: EMA recommends authorisation of two monoclonal antibody medicines.


    [2] BIO COVID-19 Therapeutic Development Tracker.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.